Analysts Set Healthpeak Properties, Inc. (NYSE:DOC) PT at $22.93

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $23.62.

Several equities research analysts have issued reports on the company. Evercore ISI raised their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, September 16th. Wells Fargo & Company cut their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. Royal Bank of Canada upped their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Scotiabank raised their price objective on shares of Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Finally, StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th.

Healthpeak Properties Stock Performance

NYSE DOC opened at $20.39 on Thursday. The firm has a market capitalization of $14.26 billion, a P/E ratio of 43.38, a price-to-earnings-growth ratio of 2.37 and a beta of 1.13. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm’s fifty day moving average price is $21.72 and its two-hundred day moving average price is $21.41. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26.

Healthpeak Properties (NYSE:DOC) last issued its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The firm had revenue of $700.40 million during the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.45 earnings per share. As a group, research analysts anticipate that Healthpeak Properties will post 1.8 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.89%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio is currently 255.32%.

Institutional Investors Weigh In On Healthpeak Properties

Institutional investors and hedge funds have recently made changes to their positions in the stock. HM Payson & Co. bought a new stake in Healthpeak Properties in the third quarter valued at approximately $25,000. S.A. Mason LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $26,000. Rise Advisors LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $29,000. Fortitude Family Office LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth $32,000. Finally, Barrett & Company Inc. bought a new position in Healthpeak Properties during the third quarter worth $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.